HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Samuel S Engel Selected Research

Pioglitazone (Actos)

9/2016A randomized clinical trial evaluating the safety and efficacy of sitagliptin added to the combination of sulfonylurea and metformin in patients with type 2 diabetes mellitus and inadequate glycemic control.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Samuel S Engel Research Topics

Disease

71Type 2 Diabetes Mellitus (MODY)
01/2022 - 04/2010
29Hypoglycemia (Reactive Hypoglycemia)
11/2020 - 04/2010
15Body Weight (Weight, Body)
10/2023 - 07/2011
6Cardiovascular Diseases (Cardiovascular Disease)
11/2017 - 11/2014
5Heart Failure
02/2018 - 07/2015
4Renal Insufficiency (Renal Failure)
10/2020 - 11/2017
4Infections
11/2019 - 01/2018
4Chronic Renal Insufficiency
02/2018 - 07/2010
4Pancreatitis
11/2017 - 01/2013
4Hyperglycemia
03/2017 - 01/2013
3Diabetes Mellitus
11/2020 - 11/2017
3Stroke (Strokes)
02/2018 - 04/2017
3Weight Gain
10/2017 - 03/2015
3Diarrhea
01/2017 - 04/2010
2Weight Loss (Weight Reduction)
10/2023 - 10/2017
2Overweight
01/2022 - 01/2022
2Neoplasms (Cancer)
11/2017 - 01/2013
2Myocardial Infarction
11/2017 - 04/2017
2Hypertension (High Blood Pressure)
11/2017 - 01/2017
2Pancreatic Neoplasms (Pancreatic Cancer)
04/2017 - 02/2017
2Constipation
01/2013 - 04/2010
1Alcoholic Fatty Liver
10/2023
1Inflammation (Inflammations)
10/2023
1Non-alcoholic Fatty Liver Disease
10/2023
1Insulin Resistance
05/2020
1Dementia (Dementias)
11/2019
1Vascular Diseases (Vascular Disease)
10/2018
1Cardiac Arrhythmias (Arrythmia)
02/2018
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
02/2018
1Hypovolemia
02/2018
1Disease Progression
11/2017
1Diabetic Neuropathies (Diabetic Neuropathy)
11/2017
1Bone Fractures (Bone Fracture)
11/2017
1Eye Diseases (Eye Disease)
11/2017
1Chronic Kidney Failure (Chronic Renal Failure)
06/2017
1Unstable Angina
04/2017
1Hyperlipidemias (Hyperlipidemia)
01/2017
1Vomiting
01/2017
1Nausea
01/2017
1Abdominal Pain (Pain, Abdominal)
01/2017
1Edema (Dropsy)
09/2016
1Albuminuria
09/2016
1Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2013
1Dyslipidemias (Dyslipidemia)
01/2013

Drug/Important Bio-Agent (IBA)

50Sitagliptin Phosphate (Januvia)FDA Link
01/2022 - 04/2010
31Metformin (Glucophage)FDA LinkGeneric
01/2022 - 04/2010
16Hypoglycemic Agents (Hypoglycemics)IBA
11/2020 - 07/2010
122- (2,5- difluorophenyl)- 5- (2- (methylsulfonyl)- 2,6- dihydropyrrolo(3,4- c)pyrazol- 5(4H)- yl)tetrahydro- 2H- pyran- 3- amineIBA
01/2021 - 11/2015
11Insulin (Novolin)FDA Link
01/2022 - 11/2012
11Glucose (Dextrose)FDA LinkGeneric
05/2020 - 03/2015
9Dipeptidyl-Peptidase IV InhibitorsIBA
11/2017 - 03/2015
6Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
11/2020 - 09/2013
6glimepiride (Amarel)FDA LinkGeneric
01/2019 - 06/2011
6ertugliflozinIBA
01/2019 - 01/2018
3Sodium-Glucose Transport ProteinsIBA
02/2018 - 02/2018
2Glucagon-Like Peptide-1 ReceptorIBA
10/2023 - 04/2010
2Glucagon Receptors (Glucagon Receptor)IBA
10/2023 - 11/2014
2AutoantibodiesIBA
01/2022 - 01/2022
2ipragliflozinIBA
01/2021 - 01/2021
2dapagliflozinIBA
10/2020 - 12/2018
2Hemoglobins (Hemoglobin)IBA
05/2020 - 01/2016
2Insulin Glargine (Lantus)FDA Link
01/2019 - 06/2015
2Glipizide (Glucotrol)FDA LinkGeneric
06/2017 - 07/2011
2CreatinineIBA
09/2016 - 07/2010
2Glucagon (Glukagon)FDA Link
11/2015 - 10/2013
2Antihypertensive Agents (Antihypertensives)IBA
11/2014 - 07/2010
2IncretinsIBA
10/2013 - 04/2010
1semaglutideIBA
10/2023
1Fatty Acids (Saturated Fatty Acids)IBA
10/2023
1Glucagon-Like Peptide 1 (GLP 1)IBA
10/2023
1Long-Acting Insulin (Insulin, Long Acting)FDA Link
11/2019
1SodiumIBA
12/2018
1Blood Glucose (Blood Sugar)IBA
02/2018
1omega-Chloroacetophenone (Mace)IBA
11/2017
1AcarboseFDA LinkGeneric
01/2017
1Pioglitazone (Actos)FDA Link
09/2016
1AlbuminsIBA
09/2016
1Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA
12/2015
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
11/2015
1N- ((4- (1- (3- (3,5- dichlorophenyl)- 5- (6- methoxynaphthalen- 2- yl)- 1H- pyrazol- 1- yl)ethyl)phenyl)carbonyl)- beta- alanineIBA
11/2015
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2013
1Simvastatin (Zocor)FDA LinkGeneric
01/2013
1Glyburide (Glibenclamide)FDA LinkGeneric
06/2011
1Gliclazide (Diamicron)IBA
06/2011
1LipidsIBA
07/2010
12,4-thiazolidinedione (thiazolidinedione)IBA
07/2010
1Exenatide (Byetta)FDA Link
04/2010

Therapy/Procedure

23Therapeutics
10/2023 - 04/2010
23Glycemic Control
01/2022 - 07/2011
1Time-to-Treatment
11/2014
1Length of Stay
02/2013
1Injections
04/2010